Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rie Kikkawa

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nucleic Acid Therapeutics|May 4, 2016
Effects of Repeated Complement Activation Associated with Chronic Treatment of Cynomolgus Monkeys with 2'-O-Methoxyethyl Modified Antisense OligonucleotideLijiang Shen, Jeffrey A Engelhardt, Gene Hung, et al.
Molecular Therapy. Methods & Clinical Development|November 10, 2025
Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vectorintrathecal injection in cynomolgus monkeysMaria Vono, Tony Del Rio, Eduardo Magdaleno, et al.
Molecular Therapy. Advances|May 15, 2026
Erratum: Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vector intrathecal injection in cynomolgus monkeysMaria Vono, Tony Del Rio, Eduardo Magdaleno, et al.
ACS Medicinal Chemistry Letters|December 17, 2021
Antitarget Selectivity and Tolerability of Novel Pyrrolo[2,3-<i>d</i>]pyrimidine RET InhibitorsCasey J N Mathison, Yang Yang, John Nelson, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Efficacy and Tolerability of Pyrazolo[1,5-<i>a</i>]pyrimidine RET Kinase Inhibitors for the Treatment of Lung AdenocarcinomaCasey J N Mathison, Donatella Chianelli, Paul V Rucker, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nucleic Acid Therapeutics|May 4, 2016
Effects of Repeated Complement Activation Associated with Chronic Treatment of Cynomolgus Monkeys with 2'-O-Methoxyethyl Modified Antisense OligonucleotideLijiang Shen, Jeffrey A Engelhardt, Gene Hung, et al.
Molecular Therapy. Methods & Clinical Development|November 10, 2025
Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vectorintrathecal injection in cynomolgus monkeysMaria Vono, Tony Del Rio, Eduardo Magdaleno, et al.
Molecular Therapy. Advances|May 15, 2026
Erratum: Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vector intrathecal injection in cynomolgus monkeysMaria Vono, Tony Del Rio, Eduardo Magdaleno, et al.
ACS Medicinal Chemistry Letters|December 17, 2021
Antitarget Selectivity and Tolerability of Novel Pyrrolo[2,3-<i>d</i>]pyrimidine RET InhibitorsCasey J N Mathison, Yang Yang, John Nelson, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Efficacy and Tolerability of Pyrazolo[1,5-<i>a</i>]pyrimidine RET Kinase Inhibitors for the Treatment of Lung AdenocarcinomaCasey J N Mathison, Donatella Chianelli, Paul V Rucker, et al.
Pageof 2